Similarly, patients with triple negative gliomas had poorer overall survival than gliomas with TERT, IDH, or triple positive gliomas.  Of note among Grade IV gliomas, the molecular subgroups assigned in this study were not associated with survival differences in multivariate analyses. This evidence concerns the gene IDH1 and glioma.